Abstract:Objective:To explore the effects of curcumin on the radiosensitivity of non-small cell lung cancer (NSCLC) A549 and H460 cells and determine the underlying mechanism as mediated by long non-coding RNA (lncRNA) homeotic complex gene anti-sense intergenic RNA (HOTAIR).Methods:NSCLC were divided into different groups according to the experimental scheme. (1) A549 and H460 cells were divided into six groups each treated by 0, 15, 30, 60, and 240 μmol/L curcumin. Cell-counting kit 8 (CCK-8) assay was performed to measure the cell viability after each treatment. (2) A549 and H460 cells were divided into eight groups of 0, 2, 4, and 6 Gy γ-irradiation treatment groups and their corresponding combinations with 30 μmol/L curcumin. CCK-8 and colony formation assays were conducted to determine the cell proliferative abilities of each group. (3) A549 cells were divided into four groups: control, 30 μmol/L curcumin treatment, 4 Gy γ-irradiation treatment, and combinational treatment of 30 μmol/L curcumin and 4 Gy γ-irradiation groups. Quantitative real-time polymerase chain reaction (qRT-PCR) analysis was performed to monitor the expression levels of five oncogenic lncRNAs and five tumor-suppressive lncRNAs in A549 cells from each group. (4) A549 cells were divided into six groups: control, 30 μmol/L curcumin treatment, 30 μmol/L curcumin+ overexpression of lncRNA HOTAIR, 4 Gy γ-irradiation treatment, combinational treatment of 30 μmol/L curcumin and 4 Gy γ-irradiation, and combinational treatment of 30 μmol/L curcumin and 4 Gy γ-irradiation+overexpression of lncRNA HOTAIR groups. The cell proliferative capacities after each treatment were detected by CCK-8 and colony formation assays. Statistical significance was determined by SPSS statistical software and analyzed by Student t-test. Results:(1) CCK-8 assay results showed that curcumin treatment decreased the cell viability of A549 and H460 cells in a dose- and time-dependent manner, and the difference between each treatment group and the control group was statistically significant ( t=3.884-5.731, P=0.000-0.043). (2) CCK-8 and colony formation assay revealed that the combinational treatment of 30 μmol/L curcumin and different γ-irradiation doses significantly promoted the further reduction of cell proliferation and colony formation abilities compared with γ-irradiation alone ( t=2.503 -12.418, P=0.000 -0.044). (3) qRT-PCR detection revealed that the expression level of lncRNA HOTAIR elevated after γ-irradiation treatment ( t=3.317, P =0.040), but the sole treatment of 30 μmol/L curcumin and the combinational treatment of 30 μmol/L curcumin with γ-irradiation could down-regulate the expression of tumor-promoting lncRNA HOTAIR in A549 cells compared with the control group ( t=3.205, 5.916, P=0.038, 0.000). (4) HOTAIR overexpression could reverse the inhibitory effects of curcumin on the cell proliferation capacity and radiation resistance of A549 cells ( t=3.584-5.802, P=0.000-0.004). Conclusion:Curcumin can suppress the cell proliferation capacity and enhance the radiation sensitivity of NSCLC by down-regulating lncRNA HOTAIR.

Effects of curcumin on the radiosensitivity of non-small cell lung cancer A549 and H460 cells

Radiosensitizing Effects of Curcumin Alone or Combined with GLUT1 Sirna on Laryngeal Carcinoma Cells Through AMPK Pathway-Induced Autophagy

Effect of Combination of Curcumin and GLUT-1 AS-ODN on Radiosensitivity of Laryngeal Carcinoma Through Regulating Autophagy

A preliminary study on radiosensitization effect of curcumin plus cisplatin on non-small cell lung cancer A549 cells

Radiosensitization Effects of Curcumin Plus Cisplatin on Non-Small Cell Lung Cancer A549 Cells

Anticancer effects of curcumin on nude mice bearing lung cancer A549 cell subsets SP and NSP cells

Influence of curcumin combined with radiotherapy on the proliferation and apoptosis of HT29 cells

Antitumor Effects of Curcumin on the Proliferation, Migration and Apoptosis of Human Colorectal Carcinoma HCT‑116 Cells.

Effect of curcumin on proliferation of human lung adenocarcinoma cell line A549/DDP

Antitumor Activity of Curcumin by Modulation of Apoptosis and Autophagy in Human Lung Cancer A549 Cells Through Inhibiting PI3K/Akt/mTOR Pathway.

Expression Analysis Of Cdc42 In Lung Cancer And Modulation Of Its Expression By Curcumin In Lung Cancer Cell Lines

Inhibitory effect and mechanism of curcumin on the growth of A549 cell line xenograft in nude mice

Curcumin Inhibits Cell Proliferation and Migration in NSCLC Through a Synergistic Effect on the TLR4/MyD88 and EGFR Pathways

Curcumin enhances cisplatin sensitivity of human NSCLC cell lines through influencing Cu-Sp1-CTR1 regulatory loop

Curcumin Inhibits the Progression of Non-small Cell Lung Cancer by Regulating DMRT3/SLC7A11 Axis

Curcumin Alters Gene Expression-Associated DNA Damage, Cell Cycle, Cell Survival and Cell Migration and Invasion in NCI-H460 Human Lung Cancer Cells in Vitro

Potential Anti-Cancer Effect of Curcumin in Human Lung Squamous Cell Carcinoma

The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer

Decoding potential targets and pharmacologic mechanisms of curcumin in treating non-small cell lung carcinoma via bioinformatics and molecular docking

Effects of curcumol on proliferation of A549 cells and expression of NF-κB and VEGF

Identification of Curcumin-Inhibited Extracellular Matrix Receptors in Non–small Cell Lung Cancer A549 Cells by RNA Sequencing